Global Boardrooms Sceptical About Potential For UK To Be Lifesciences Superpower
The UK has the potential to fulfill its ambition of being a global superpower in life sciences, but it must not get lost in an echo chamber, says a senior MSD executive.
You may also be interested in...
The UK drug regulator, the MHRA, has approved its first product under Project Orbis, the US-led international regulatory collaboration scheme it joined four months ago to speed up access to promising cancer medicines.
More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.